Deutsche Bank AG Acquires 19,659 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)

Deutsche Bank AG lifted its holdings in Health Catalyst, Inc. (NASDAQ:HCAT) by 9.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 225,768 shares of the company’s stock after purchasing an additional 19,659 shares during the period. Deutsche Bank AG owned about 0.37% of Health Catalyst worth $1,596,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Quantbot Technologies LP bought a new position in shares of Health Catalyst in the 4th quarter worth approximately $29,000. Aquatic Capital Management LLC purchased a new stake in Health Catalyst in the 4th quarter worth approximately $63,000. Stoneridge Investment Partners LLC purchased a new stake in Health Catalyst in the 4th quarter worth approximately $77,000. Martin Worley Group purchased a new stake in Health Catalyst in the 4th quarter worth approximately $78,000. Finally, Brevan Howard Capital Management LP purchased a new stake in Health Catalyst in the 4th quarter worth approximately $92,000. Institutional investors own 85.00% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on HCAT shares. Stephens reduced their target price on shares of Health Catalyst from $7.00 to $5.00 and set an “equal weight” rating for the company in a report on Thursday, March 6th. KeyCorp reduced their target price on shares of Health Catalyst from $7.00 to $5.00 and set an “overweight” rating for the company in a report on Wednesday, April 16th. Citigroup reduced their target price on shares of Health Catalyst from $7.00 to $6.50 and set a “buy” rating for the company in a report on Friday, April 25th. Piper Sandler reduced their target price on shares of Health Catalyst from $12.00 to $8.00 and set an “overweight” rating for the company in a report on Tuesday, February 11th. Finally, Evercore ISI lowered shares of Health Catalyst from an “outperform” rating to an “inline” rating in a report on Wednesday, April 9th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $8.00.

Insider Activity

In other news, COO Daniel Lesueur sold 16,902 shares of the stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $4.52, for a total transaction of $76,397.04. Following the completion of the transaction, the chief operating officer now directly owns 216,250 shares in the company, valued at approximately $977,450. This represents a 7.25% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Benjamin Landry sold 13,827 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $4.55, for a total value of $62,912.85. Following the transaction, the general counsel now owns 160,437 shares of the company’s stock, valued at $729,988.35. This represents a 7.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 41,147 shares of company stock worth $182,284. 2.50% of the stock is currently owned by insiders.

Health Catalyst Trading Down 0.3%

Shares of HCAT opened at $3.65 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. The firm has a market cap of $254.04 million, a P/E ratio of -2.70 and a beta of 1.56. Health Catalyst, Inc. has a 1 year low of $3.54 and a 1 year high of $9.24. The company has a 50 day simple moving average of $4.07 and a two-hundred day simple moving average of $5.65.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.